Revenue
47.3 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 47281085 USD Source
Fundies. English
Immudyne, Inc.
EDGARAnnual consolidated revenue for 2025: about USD 194.1M, using the latest reported figures. The previous period, 2024, was about USD 154.8M.
Latest quarter
Operating margin
-15.08%
2026 Q2 · %
Operating cash flow
-6.93 million USD
2026 Q2 · USD
Free cash flow
-6.99 million USD
2026 Q2 · USD
- Cash and cash equivalents
- 36.2 million USD Source
Exact value
36200000 USD
- Long-term debt including current maturities
- 15.9 million USD Source
Exact value
15900000 USD
- Shares outstanding
- 47.8 million shares Source
Exact value
47820492 shares
Reported share-count change
6.18% · 2.78 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
165 million USD
2025-07-01 – 2026-06-30
Net income
201 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
-9.91 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: 11560698 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: 11707834 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: 8280175 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: 11560698 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: 444624 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -6481023 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: 444624 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-05.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 11 of 11 periods available· newest 2025-12-31
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- Capital expenditure: 5 of 11 periods available· newest 2025-12-31
- Total assets: 11 of 11 periods available· newest 2025-12-31
- Total liabilities: 10 of 11 periods available· newest 2025-12-31
- Current assets: 11 of 11 periods available· newest 2025-12-31
- Current liabilities: 11 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 10 of 11 periods available· newest 2024-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 11 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+25.3%Prior period
USD 154.82 million
–
Current period
USD 194.06 million
–
Exact inputs and evidence
194055198 − 154824075 = 39231123 USD
154824075 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source194055198 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 35.76 millionPrior period
−USD 21.41 million
–
Current period
USD 14.35 million
–
Exact inputs and evidence
14354106 − -21409016 = 35763122 USD
-21409016 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source14354106 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-52.7%Prior period
USD 17.51 million
–
Current period
USD 8.28 million
–
Exact inputs and evidence
8280175 − 17513190 = -9233015 USD
17513190 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source8280175 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+27.8%Prior period
USD 1.46 million
–
Current period
USD 1.87 million
–
Exact inputs and evidence
1870668 − 1463357 = 407311 USD
1463357 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1870668 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 194.06 million 100% of revenue
- Cost of revenue USD 27.71 million 14% of revenue
- Operating expenses USD 174.01 million 90% of revenue
- Operating income −USD 7.67 million −4% of revenue
- Tax, interest and other Derived −USD 22.02 million −11% of revenue
- Net income USD 14.35 million 7.4% of revenue
Cash
- Operating cash flow USD 8.28 million 4.3% of revenue
- Capital expenditure USD 1.87 million 1% of revenue
- Free cash flow Derived USD 6.41 million 3.3% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2016 Operating loss: operating costs were 122% of revenue.
- 2017 Operating loss: operating costs were 133% of revenue.
- 2018 Operating loss: operating costs were 4,936% of revenue.
- 2019 Operating loss: operating costs were 123% of revenue.
- 2020 Operating loss: operating costs were 255% of revenue.
- 2021 Operating loss: operating costs were 158% of revenue.
- 2022 Operating loss: operating costs were 137% of revenue.
- 2023 Operating loss: operating costs were 109% of revenue.
- 2024 Operating loss: operating costs were 113% of revenue.
- 2025 Operating loss: operating costs were 104% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | 5238604 | 6413286 Derived | -1174682 | -67138 Derived | -1107544 | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 3681827 | 4910182 Derived | -1228355 | -22394 Derived | -1205961 | Unavailable | Source
|
| 2018 2018-01-01 – 2018-12-31 | 42515 | 2098655 Derived | -2056140 | -815312 Derived | -1240828 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 12468578 | 15358186 Derived | -2889608 | 247595 Derived | -3137203 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 37293910 | 95113363 Derived | -57819453 | 827490 Derived | -58646943 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 92875806 | 147176887 Derived | -54301081 | 6596623 Derived | -60897704 | -33332854 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 119033520 | 162481301 Derived | -43447781 | 2087878 Derived | -45535659 | -23301782 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 152547006 | 167036279 Derived | -14489273 | 6106719 Derived | -20595992 | 8616418 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 154824075 | 175226063 Derived | -20401988 | 1007028 Derived | -21409016 | 16049833 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 194055198 | 201724892 Derived | -7669694 | -22023800 Derived | 14354106 | 6409507 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 194.1M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 5238604 |
|
| 2017 | Revenue | 3681827 |
|
| 2018 | Revenue | 42515 |
|
| 2019 | Revenue | 12468578 |
|
| 2020 | Revenue | 37293910 |
|
| 2021 | Revenue | 92875806 |
|
| 2022 | Revenue | 119033520 |
|
| 2023 | Revenue | 152547006 |
|
| 2024 | Revenue | 154824075 |
|
| 2025 | Revenue | 194055198 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
25.3% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | 329.8% |
|
| 2017 | Year over year | -29.7% |
|
| 2018 | Year over year | -98.8% |
|
| 2019 | Year over year | 29,227.5% |
|
| 2020 | Year over year | 199.1% |
|
| 2021 | Year over year | 149% |
|
| 2022 | Year over year | 28.2% |
|
| 2023 | Year over year | 28.2% |
|
| 2024 | Year over year | 1.5% |
|
| 2025 | Year over year | 25.3% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -4% 2025
Net margin 7.4% 2025
Free cash flow margin 3.3% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | -22.4% |
|
| 2017 | Operating margin | -33.4% |
|
| 2018 | Operating margin | -4,836.3% |
|
| 2019 | Operating margin | -23.2% |
|
| 2020 | Operating margin | -155% |
|
| 2021 | Operating margin | -58.5% |
|
| 2022 | Operating margin | -36.5% |
|
| 2023 | Operating margin | -9.5% |
|
| 2024 | Operating margin | -13.2% |
|
| 2025 | Operating margin | -4% |
|
| 2016 | Net margin | -21.1% |
|
| 2017 | Net margin | -32.8% |
|
| 2018 | Net margin | -2,918.6% |
|
| 2019 | Net margin | -25.2% |
|
| 2020 | Net margin | -157.3% |
|
| 2021 | Net margin | -65.6% |
|
| 2022 | Net margin | -38.3% |
|
| 2023 | Net margin | -13.5% |
|
| 2024 | Net margin | -13.8% |
|
| 2025 | Net margin | 7.4% |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | -35.9% |
|
| 2022 | Free cash flow margin | -19.6% |
|
| 2023 | Free cash flow margin | 5.6% |
|
| 2024 | Free cash flow margin | 10.4% |
|
| 2025 | Free cash flow margin | 3.3% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 8.3M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | -407914 |
|
| 2017 | Operating cash flow | -817216 |
|
| 2018 | Operating cash flow | -905519 |
|
| 2019 | Operating cash flow | 251408 |
|
| 2020 | Operating cash flow | -12131614 |
|
| 2021 | Operating cash flow | -33085489 |
|
| 2022 | Operating cash flow | -22935149 |
|
| 2023 | Operating cash flow | 8820232 |
|
| 2024 | Operating cash flow | 17513190 |
|
| 2025 | Operating cash flow | 8280175 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD 6.4M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | -33332854 |
|
| 2022 | Free cash flow | -23301782 |
|
| 2023 | Free cash flow | 8616418 |
|
| 2024 | Free cash flow | 16049833 |
|
| 2025 | Free cash flow | 6409507 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
67.1% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016-12-31 | Liabilities / assets | Not reported |
|
| 2017 | Liabilities / assets | 50.7% |
|
| 2018 | Liabilities / assets | 68.7% |
|
| 2019 | Liabilities / assets | 132.8% |
|
| 2020 | Liabilities / assets | 106.1% |
|
| 2021 | Liabilities / assets | 48.3% |
|
| 2022 | Liabilities / assets | 128.5% |
|
| 2023 | Liabilities / assets | 90.5% |
|
| 2024 | Liabilities / assets | 109.9% |
|
| 2025 | Liabilities / assets | 67.1% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
1.25× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 0.69× |
|
| 2017 | Current assets / current liabilities | 1.97× |
|
| 2018 | Current assets / current liabilities | 1.35× |
|
| 2019 | Current assets / current liabilities | 0.69× |
|
| 2020 | Current assets / current liabilities | 0.89× |
|
| 2021 | Current assets / current liabilities | 1.97× |
|
| 2022 | Current assets / current liabilities | 0.36× |
|
| 2023 | Current assets / current liabilities | 1.22× |
|
| 2024 | Current assets / current liabilities | 0.78× |
|
| 2025 | Current assets / current liabilities | 1.25× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | −USD 1.11 million Exact valueExact value: -1107544 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 407,914 Exact valueExact value: -407914 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | −USD 1.21 million Exact valueExact value: -1205961 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 817,216 Exact valueExact value: -817216 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | −USD 1.24 million Exact valueExact value: -1240828 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 905,519 Exact valueExact value: -905519 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 3.14 million Exact valueExact value: -3137203 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 251,408 Exact valueExact value: 251408 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 58.65 million Exact valueExact value: -58646943 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.13 million Exact valueExact value: -12131614 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 60.9 million Exact valueExact value: -60897704 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 33.09 million Exact valueExact value: -33085489 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 247,365 Exact valueExact value: 247365 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 33.33 million Calculation and evidence-33085489 − 247365 USD Exact free cash flow: -33332854 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 45.54 million Exact valueExact value: -45535659 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22.94 million Exact valueExact value: -22935149 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 366,633 Exact valueExact value: 366633 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 23.3 million Calculation and evidence-22935149 − 366633 USD Exact free cash flow: -23301782 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 20.6 million Exact valueExact value: -20595992 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8.82 million Exact valueExact value: 8820232 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 203,814 Exact valueExact value: 203814 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8.62 million Calculation and evidence8820232 − 203814 USD Exact free cash flow: 8616418 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 21.41 million Exact valueExact value: -21409016 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 17.51 million Exact valueExact value: 17513190 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.46 million Exact valueExact value: 1463357 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 16.05 million Calculation and evidence17513190 − 1463357 USD Exact free cash flow: 16049833 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | USD 14.35 million Exact valueExact value: 14354106 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8.28 million Exact valueExact value: 8280175 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.87 million Exact valueExact value: 1870668 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6.41 million Calculation and evidence8280175 − 1870668 USD Exact free cash flow: 6409507 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
75 filings · 4,957 latest values · 4,957 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000948320, 948320, CVLB, IMMD, LFMD, LFMDP, edgar:948320, immd
Also known as CONVERSION LABS, INC., Immudyne, Inc., LIFEMD, INC., LIFEMD, INC., LifeMD, Inc.